Development and Validation of a UPLC–MS/MS for Determination of Loureirin D in Rat Plasma and Its Application to Pharmacokinetics
Biomedical Chromatography · 2026-08 · 40 (8)
DOI: 10.1002/bmc.70547 ↗Kurz gefasst
Fachartikel in der Zeitschrift Biomedical Chromatography, online erschienen am 11.07.2026. Verfasst von Yi Zhou und 6 weiteren Autor:innen. Beteiligte Einrichtung: The Second Affiliated Hospital Zhejiang University School of Medicine Linping Campus, Hangzhou, China. Hauptthemen laut MEDLINE: Tandem Mass Spectrometry, Liquid Chromatography-Mass Spectrometry, Chalcones. Die Arbeit nennt 29 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar. Gefördert von: Zhejiang Province Medical and Health Science and Technology Plan Project.
Abstract (Originalsprache)
Loureirin D is a bioactive dihydrochalcone isolated from Dracaena resin with very high therapeutic value. A sensitive and high‐throughput ultra‐performance liquid chromatography–mass spectrometry (UPLC–MS/MS) method was developed for the quantitative analysis of loureirin D in rat plasma with only 50 μL of sample per assay. Sample extraction was protein precipitation using acetonitrile, and isoscoparin was used as internal standard (IS). Separation was achieved on the BEH C18 column with a gradient mobile phase of 0.1% (v/v) aqueous formic acid and acetonitrile. Detection was achieved with negative‐ion electrospray ionization (ESI) detector in the multiple reaction monitoring (MRM) mode. The method was validated and proved to be linear in the concentration range of 2–2400 ng/mL ( r ≥ 0.995), intraday and interday precision (RSD) was < 15%, and accuracy was 93.3%–110.1%. The extraction recovery was 88.7%–94.4%, and the matrix effects were 87.3%–92.9%. UPLC‐MS/MS was used in pharmacokinetics in the rats after administration of loureirin D. The AUC (0– t ) after intravenous administration (1 mg/kg) was 2074.7 ± 180.3 ng · h/mL, and AUC (0– t ) after oral administration (5 mg/kg) was 563.4 ± 61.4 ng · h/mL; the absolute oral bioavailability was 5.4%. Pharmacokinetics showed rapid absorption, large V z / F (52.7 ± 10.7 L/kg), high CL z / F (8.8 ± 0.9 L/h/kg), and extensive first‐pass metabolism.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- The Second Affiliated Hospital Zhejiang University School of Medicine Linping Campus, Hangzhou, China.
- Laboratory Animal Centre, Wenzhou Medical University, Wenzhou, China.
- School of Pharmaceutical Sciences, Wenzhou Medical University, Wenzhou, China.
ORCID-Profile: Congcong Wen, Xianqin Wang, Jianbo Li
Förderung
- Zhejiang Province Medical and Health Science and Technology Plan Project
Zitieren
APA
Zhou, Y., Wu, Y., Xu, C., Zhang, C., Wen, C., Wang, X., & Li, J. (2026). Development and Validation of a UPLC–MS/MS for Determination of Loureirin D in Rat Plasma and Its Application to Pharmacokinetics. Biomedical Chromatography, 40(8). https://doi.org/10.1002/bmc.70547
Vancouver
Zhou Y, Wu Y, Xu C, Zhang C, Wen C, Wang X, et al. Development and Validation of a UPLC–MS/MS for Determination of Loureirin D in Rat Plasma and Its Application to Pharmacokinetics. Biomedical Chromatography. 2026;40(8). doi:10.1002/bmc.70547
BibTeX
@article{Zhou2026,
author = {Zhou, Yi and Wu, Yuxin and Xu, Chenyao and Zhang, Chenbin and Wen, Congcong and Wang, Xianqin and Li, Jianbo},
title = {Development and Validation of a UPLC–MS/MS for Determination of Loureirin D in Rat Plasma and Its Application to Pharmacokinetics},
journal = {Biomedical Chromatography},
year = {2026},
volume = {40},
number = {8},
doi = {10.1002/bmc.70547}
}
EUVIMED